Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
empagliflozin medium dose
DRUG
2 trials
Sponsors
Boehringer Ingelheim
Conditions
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Phase 1
Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus
Completed
NCT02121483
Boehringer Ingelheim
Diabetes Mellitus, Type 2
Start: 2014-06-30
End: 2016-02-29
Updated: 2016-09-19
Phase 2
Empa Add on to Insulin in Japanese Patient With Type 1 Diabetes Mellitus
Completed
NCT02702011
Boehringer Ingelheim
Diabetes Mellitus, Type 1
Start: 2016-03-20
End: 2016-10-03
Updated: 2018-04-02
Related Papers
The Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth with Type 2 Diabetes
Diabetes
2018-06-22
2 citations
Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4-week, double-blind, randomized, placebo-controlled phase 2 trial.
2018-06-05
31 citations
Pharmacokinetic and pharmacodynamic profile of the sodium-glucose co-transporter-2 inhibitor empagliflozin in young people with Type 2 diabetes: a randomized trial.
2018-05-06
42 citations